ArticleScientific reports2021

Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in Austria.

Cihan Ay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.